Neuropathic Pain
📧 Sign up to get email alerts when something new happens for Neuropathic Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-05-13FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA granted supplemental approval for gabapentin submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2009-12-15FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Carbamazepine (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2009-11-25FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Carbamazepine from Apotex Corp.
-
FDA approval · 2008-04-14FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, indicating regulatory clearance for a…
-
FDA approval · 2007-06-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride from Sandoz Inc., enabling regulatory clearance for this generic pro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-05-03FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Div of Pfizer Inc.